Phase II trial of bevacizumab plus pemetrexed and carboplatin in previously untreated advanced nonsquamous non-small cell lung cancer

被引：0
|
作者：
Dalsania, C. J. [1 ]
Hageboutros, A. [1 ]
Harris, E. [1 ]
Krieger, K. [1 ]
Vora, C. [1 ]
Stevenson, J. [1 ]
机构：
[1] Cooper Univ Hosp, Camden, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18163
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab for Japanese nonsquamous non-small cell lung cancer
    Yokoi, Takashi
    Torii, Yoshitaro
    Katashiba, Yuichi
    Sugimoto, Hiroyuki
    Hayashi, Mina
    Shimizu, Toshiki
    Nomura, Shosaku
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer
    Yabuki, Yohei
    Hanibuchi, Masaki
    Takeuchi, Eiji
    Haku, Takashi
    Kanematsu, Takanori
    Nishimura, Naoki
    Toyoda, Yuko
    Mitsuhashi, Atsushi
    Otsuka, Kenji
    Sato, Seidai
    Goto, Hisatsugu
    Yoneda, Hiroto
    Ogino, Hirokazu
    Nokihara, Hiroshi
    Tsutomu, Shinohara
    Nishioka, Yasuhiko
    [J]. THORACIC CANCER, 2023, 14 (32) : 3232 - 3239
  • [3] An Open-Label Phase II Trial of Bevacizumab plus Docetaxel and Gemcitabine in Advanced, Previously Untreated Nonsquamous Non-Small Cell Lung Cancer
    Patil, Pradnya Dinkar
    Shapiro, Marc
    Sadraei, Nooshin Hashemi
    Pennell, Nathan A.
    [J]. ONCOLOGIST, 2019, 24 (04): : 457 - E126
  • [4] Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non-small-cell lung cancer
    Laslett, Nicole F.
    Park, Sujung
    Masters, Gregory A.
    Biggs, David D.
    Schneider, Charles J.
    Misleh, Jamal G.
    Suppiah, Kathir
    Simpson, Pamela S.
    Grubbs, Stephen
    Wozniak, Timothy F.
    Guarino, Michael
    [J]. CANCER MEDICINE, 2018, 7 (07): : 2969 - 2973
  • [5] Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small cell lung cancer
    Shipley, D.
    Spigel, D. R.
    Burris, H. A., III
    Waterhouse, D. M.
    Webb, C. D.
    Gian, V.
    Hart, L. L.
    Greco, F. A.
    Hainsworth, J. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] A phase II trial of first-line bevacizumab in combination with pemetrexed and carboplatin in advanced nonsquamous non-small cell lung cancer (NSCLC)
    Skaff, Z. G.
    Hageboutros, A.
    Krieger, K.
    Coakley, S.
    Somer, R.
    Stevenson, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] PHASE II TRIAL OF PEMETREXED AND CARBOPLATIN FOLLOWED BY PEMETREXED CONTINUATION-MAINTENANCE THERAPY IN PREVIOUSLY UNTREATED ADVANCED NON-SMALL CELL LUNG CANCER
    Nishino, Kazumi
    Kijima, Takashi
    Minami, Seigo
    Komuta, Kiyoshi
    Kumagai, Toru
    Imamura, Fumio
    Yokota, Soichiro
    Takeuchi, Yoshiko
    Nakatani, Takeshi
    Uchida, Junji
    Okuyama, Takako
    Tachibana, Isao
    Kawase, Ichiro
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S861 - S862
  • [8] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
    Guarino, Michael J.
    Masters, Gregory A.
    Biggs, David D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
  • [9] Phase II trial of bevacizumab, cisplatin, and pemetrexed in Japanese patients with advanced nonsquamous non-small cell lung cancer.
    Yanagitani, Noriko
    Ohyanagi, Fumiyoshi
    Nishizawa, Hironari
    Gyotoku, Hiroshi
    Uenami, Takeshi
    Kobayashi, Hlroshi
    Kudo, Kelta
    Tambo, Yuichi
    Horilke, Atsushi
    Hagiwara, Sachiko
    Horai, Takeshi
    Nishio, Makoto
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] The efficacy and safety of pemetrexed plus bevacizumab in previously treated patients with advanced nonsquamous non-small cell lung cancer.
    Ding, Lingyu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345